Thursday, April 28, 2016

Abbott Agreed to Buy St. Jude in $25 Billion Deal

Abbott Laboratories agreed to acquire St. Jude Medical in a cash-and-stock deal valued at $25 billion that merges two of the leading makers of heart-related devices.

from WSJ.com: US Business http://ift.tt/24m4S2y
via IFTTT

No comments:

Post a Comment